Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This is a 4‐week randomized, open‐label trial to investigate the efficacy and safety of loxoprofen sodium hydrogel patch (LX‐P) versus loxoprofen sodium tablet (LX‐T) in patients with active ankylosing spondylitis(AS). The trial includes 70 patients who are randomly assigned to either the LX‐P group (LX‐P 100 mg per day) or LX‐T group (LX‐T 60 mg t.i.d.) for 4 weeks.
Epistemonikos ID: 1d99bf886b0018677b1357327224d32587f02d74
First added on: May 21, 2024